3
World Cancer Day: Start-ups at the IZB develop innovative cancer drugs and diagnostic tools
One document
more
Stories about Pharmaindustrie
Merger: Newly-formed Semdor Pharma Group becomes one of Europe's leading pharmaceutical companies for narcotics and medical cannabis
moreEleva Secures up to EUR 60 million to Advance a Drug Candidate, Appoints New Board Member
Freiburg (ots) - Eleva, a manufacturer of superior biologics, has secured up to EUR 60 million in funding from Zukunftsfonds Heilbronn (ZFHN). The funds will help advance one of its drug candidates, CPV-101, to stages that will facilitate further investment from venture capitalists and/or pharmaceutical companies. Eleva also announced the addition of Dr. Ralf Smit to ...
moreSysmex Inostics Presents Data at the American Society of Hematology Annual Meeting Demonstrating Exquisite Sensitivity of SafeSEQ NGS Technology for Detection of Measurable Residual Disease in Acute Myeloid Leukemia
Baltimore, MD (ots) - Sysmex Inostics, Inc., a global leader and pioneer in blood-based, high-sensitivity molecular testing for oncology, is presenting the poster "Ultrasensitive Measurable Residual Disease (MRD) Detection in Acute Myeloid Leukemia (AML) Using a Targeted Next Generation Sequencing (NGS) Panel" at ...
more- 5
Commemorative publication for the 25th anniversary of the IZB presents 70 profiles and visions of successful biotech start-ups
One documentmore New: Combined rapid test for Covid-19 and influenza
more
EvoBiotiX collaborates with Boehringer Ingelheim and the University of Salzburg on naturally derived Extracellular Vesicles (EVs)
Salzburg/Melide(CH) (ots) - Swiss Biotech EvoBiotiX SA today announced a multi-year collaboration with Boehringer Ingelheim in the field of naturally derived EVs. A significant part of this program will fund research of the drug delivery potential of naturally derived EVs in the group of Prof. Meisner-Kober at the ...
moreTechnische Universität München
An alternative to animal experiments - New applications for organoids from human intestinal tissue
Corporate Communications Center phone: +49 8161 5403 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/36252/ Images for journalists: https://mediatum.ub.tum.de/1576619 NEWS RELEASE New applications for organoids from human intestinal ...
moreNTT DATA Business Solutions AG
2it.lifesciences for plasma: Accelerator for the human blood plasma manufacturing industry
moreKORSCH Introduces Next-Generation Mid-Range Tablet Press
moreVersameb raises CHF 6 million and strengthens team to advance its VERSagile technology platform towards clinical trials
Basel, Switzerland (ots) - Versameb AG, a biopharmaceutical company developing innovative ribonucleic acid (RNA) therapeutics, announced today the closing of a CHF 6 million seed financing round. Versameb further strengthens its team by the appointment of Dr. Klaas P. Zuideveld as Chief Development Officer effective ...
moreIgNova files patent application on antibody against COVID-19
Visbek, Germany (ots) - IgNova announced today that it has filed a patent application covering the use of passive immunization to control SARS-CoV-2 infection in humans. IgNova, a biopharmaceutical R&D start up, researches technology based on specific egg immunoglobulins (IgY). The patented IgY binds the spike protein of SARS-CoV-2, neutralizing the virus when it enters the mouth or nose and, therefore, inhibiting the ...
more
HAPA pharm receives GMP certification / Quality assured medical cannabis products
Dortmund (ots) - HAPA pharm ("HAPA" or the "Company") operates production facilities in North Macedonia to grow and process medical cannabis for the sale of pharmaceutical cannabis flos and extracts. On May 1st 2020, the Company has successfully received GMP (Good Manufacturing Practice) approval for both facilities. This milestone demonstrates HAPA's commitment ...
moreEleva's drug candidate to be examined for use in Covid-19 treatment
Freiburg (ots) - Eleva, a manufacturer of superior biologics, is exploring the potential of one of its drug candidates for first-in-line therapy of Covid-19. The compound, factor H, is part of the complement system, which is believed to affect the severity of the course of Covid-19. Eleva has developed factor H previously for a different indication and taken it through ...
moreUsing Health Data: A Sustainable Alternative to Big Tech / Ocean Protocol and Zühlke team up to push an open data economy for healthcare (FOTO)
moreSysmex Inostics' updated SafeSEQ Breast Cancer Panel advances novel clinical uses of ctDNA through quantitative testing
Baltimore, Maryland (ots) - Building on the ultra-high sensitivity SafeSEQ Breast Cancer Panel circulating tumor DNA (ctDNA) test launched at the American Association of Cancer Research 2019 annual meeting, Sysmex Inostics has updated the test to provide additional key information for investigation of the validity ...
moreNew in-vivo study confirms that ciliate vaccine protects against flu
moreBrenntag and KRONOS enter into an exclusive Sales & Marketing partnership on Titanium Dioxide for Life Science segment in Asia Pacific
Dear all, Please find attached Brenntag's press release regarding the exclusive distribution agreement for KRONOS specialty Titanium Dioxide grades marketed into the Pharma, Personal Care, and Food and Nutrition industries in ...
more
Brenntag and INABATA FRANCE SAS announce exclusive distribution partnership in the DACH region
Dear all, Please find attached Brenntag's press release regarding the exclusive sales and marketing distribution partnership of Brenntag GmbH and INABATA France SAS for INABATA's cosmetic actives ingredients in Germany, Austria and Switzerland (DACH). For further information ...
moreEuropean Association of E-Pharmacies (EAEP)
EAMSP kicks off information campaign about digitization in German healthcare sector / Fighting the allergic reaction to anything new with #neuschnupfen
moreWorldwide first and only shotgun lipidomics service provider with official GMP certificate
Dresden / Germany (ots) - Good Manufacturing Practices (GMP) ensure safety and quality of pharmaceutical products. Lipotype is the worldwide first and only officially GMP certified shotgun lipidomics service provider for pharmaceutical applications. Quality variations can pose direct threats to patient health - especially in the pharma industry. This is why quality ...
moreBrenntag to distribute innovative ESTERLAC emulsifier and surfactant range for cosmetic industry in Europe
Dear all, Please find attached a press release of Brenntag regarding the distribution of Corbion´s newly launched range of ESTERLAC (Trademark) emulsifiers and surfactants to cosmetics customers in key European markets. For ...
moreMundipharma EDO GmbH: US FDA Grants Orphan Drug Designation for Tinostamustine in Very Rare Blood Cancer
Basel, Switzerland (ots/PRNewswire) - FOR EX-US MEDICAL AND TRADE MEDIA ONLY - T-cell prolymphocytic leukaemia is an extremely rare and aggressive T-cell leukaemia, with very limited effective treatment options1,2 - Tinostamustine is in very early phase clinical trials to investigate it as a potential future ...
moreLEUKOCARE Announces Appointment of Dr Andreas Seidl as new Chief Operating Officer and member of the Executive Board
Munich, Germany (ots) - Dr Andreas Seidl, hired as new Chief Operating Officer and member of the Executive Board, will be responsible for managing R&D operations as well as quality and regulatory, logistics and intellectual property of LEUKOCARE AG. He will assume his new role on April 1, 2019. Munich-based ...
more
A new force in the European chemical and pharmaceutical engineering sector: TTP AG is now also acquiring the French subsidiary of NNE A/S
Frankfurt am Main/Copenhagen (ots) - TTP AG, Frankfurt/Main and its subsidiary TTP France S.A.S. are now also acquiring NNE S.A.S., the French engineering arm of the Danish company NNE A/S with 87 employees at the pharmaceutical industry sites in Paris, Lyon and Chartres. Three weeks ago, TTP AG and NNE A/S ...
moreSysmex Inostics' OncoBEAM(TM) demonstrates clinical validity and superior performance versus pan-cancer NGS for blood-based mutation detection for hepatocellular carcinoma
Hamburg, Germany (ots) - Data recently published in Clinical Cancer Research (http://ots.de/0ZGZkf) the advantages of using an ultra-high sensitivity test for detection of mutations which may predict therapeutic efficacy for hepatocellular carcinoma (HCC). Sysmex Inostics' OncoBEAM technology, a highly clinically ...
morePHARMAPLAN returns: TTP AG buys European engineering companies from NNE A/S
Frankfurt am Main / Copenhagen (ots) - TTP AG, Frankfurt/Main and it's subsidiary TTP GmbH, has signed an agreement with the Danish NNE A/S in Copenhagen for the purchase of three NNE subsidiaries based in Switzerland, Germany and Belgium. TTP AG is an operational holding company specialising in production-related engineering services for the process industry. It is ...
moreDr. Klemens Schulz appointed CPO of the L&R Corporate Group
moreSysmex Inostics' OncoBEAM(TM) liquid biopsy technology demonstrates utility for clinical management of melanoma patients undergoing treatment with targeted therapy and immune checkpoint inhibitors
Hamburg, Germany (ots) - Sysmex Inostics, a pioneer in blood-based circulating tumor DNA (ctDNA) analysis and molecular diagnostics for oncology, is pleased to announce publication of a study in the Journal of Molecular Oncology highlighting the important clinical value of blood-based ctDNA mutation testing to ...
moreB. Braun Medical acquires Dismed's hand sanitizer and intravenous fluid businesses in South Africa / Commitment to growth and local manufacturing for the African healthcare sector
Melsungen/Johannesburg (ots) - On 30 June 2016, B. Braun Medical, the South African subsidiary of the German B. Braun Group, completed its acquisition of Dismed Pharmaceutical (Pty) Ltd and Dismed Criticare (Pty) Ltd, both out of business rescue. With over 600 employees in South Africa, B. Braun specialises in the ...
more
Previous123456Next